Certified by Founder Lodge
ImpriMed, Inc.
![ImpriMed, Inc.](/images/flags/US.png)
START UP
1 Disclosed Funding Rounds $23,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed’s key product, Personalized Prediction Profile, has been used by board-cer
Date | Round | Raised | Participating Investors |
---|---|---|---|
December, 20 ,2023 | Series A | $23,000,000 |